Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data.

Witjes JA, Gomella LG, Stenzl A, Chang SS, Zaak D, Grossman HB.

Urology. 2014 Jul;84(1):122-6. doi: 10.1016/j.urology.2014.03.006. Epub 2014 Apr 24.

PMID:
24768013
[PubMed - indexed for MEDLINE]
2.

Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.

Yang LP.

Mol Diagn Ther. 2014 Feb;18(1):105-16. doi: 10.1007/s40291-013-0068-x. Review.

PMID:
24248555
[PubMed - indexed for MEDLINE]
3.

Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?

Geavlete B, Multescu R, Georgescu D, Jecu M, Stanescu F, Geavlete P.

BJU Int. 2012 Feb;109(4):549-56. doi: 10.1111/j.1464-410X.2011.10374.x. Epub 2011 Jun 28.

PMID:
21711438
[PubMed - indexed for MEDLINE]
4.

[Initial experience in the diagnosis and treatment of superficial bladder tumors with Hexvix].

Abascal Junquera JM, Hevia Suárez M, Abascal García JM, Estébanez C, Astudillo A, Abascal R.

Arch Esp Urol. 2008 May;61(4):475-82; discussion 482-3. Spanish.

PMID:
18592765
[PubMed - indexed for MEDLINE]
5.

A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.

Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ; PC B302/01 Study Group.

J Urol. 2007 Jul;178(1):62-7. Epub 2007 May 11.

PMID:
17499283
[PubMed - indexed for MEDLINE]
6.

Hexaminolevulinate fluorescence cystoscopy and transurethral resection of the bladder in noninvasive bladder tumors.

Geavlete B, Multescu R, Georgescu D, Geavlete P.

J Endourol. 2009 Jun;23(6):977-81. doi: 10.1089/end.2008.0574.

PMID:
19473068
[PubMed - indexed for MEDLINE]
7.

Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?

Loidl W, Schmidbauer J, Susani M, Marberger M.

Eur Urol. 2005 Mar;47(3):323-6. Epub 2004 Dec 30.

PMID:
15716195
[PubMed - indexed for MEDLINE]
8.

Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.

Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Drăgoescu O, Ray E, Fradet Y, Karl A, Burgués JP, Witjes JA, Stenzl A, Jichlinski P, Jocham D.

Eur Urol. 2013 Nov;64(5):846-54. doi: 10.1016/j.eururo.2013.03.059. Epub 2013 Apr 8. Review.

PMID:
23602406
[PubMed - indexed for MEDLINE]
9.

Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial.

Gkritsios P, Hatzimouratidis K, Kazantzidis S, Dimitriadis G, Ioannidis E, Katsikas V.

Int Urol Nephrol. 2014 May;46(5):927-33. doi: 10.1007/s11255-013-0603-z. Epub 2013 Nov 19.

PMID:
24249423
[PubMed - indexed for MEDLINE]
10.

A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.

Lapini A, Minervini A, Masala A, Schips L, Pycha A, Cindolo L, Giannella R, Martini T, Vittori G, Zani D, Bellomo F, Cosciani Cunico S.

Surg Endosc. 2012 Dec;26(12):3634-41. doi: 10.1007/s00464-012-2387-0. Epub 2012 Jun 23.

PMID:
22729704
[PubMed - indexed for MEDLINE]
11.

Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.

Malmström PU, Grabe M, Haug ES, Hellström P, Hermann GG, Mogensen K, Raitanen M, Wahlqvist R.

Scand J Urol Nephrol. 2012 Apr;46(2):108-16. doi: 10.3109/00365599.2011.633279. Epub 2011 Nov 16.

PMID:
22087730
[PubMed - indexed for MEDLINE]
12.

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.

Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, Muschter R, Popken G, König F, Knüchel R, Kurth KH.

J Urol. 2005 Sep;174(3):862-6; discussion 866.

PMID:
16093971
[PubMed - indexed for MEDLINE]
13.

HAL fluorescence cystoscopy and TURB one year of Romanian experience.

Geavlete B, Mulţescu R, Georgescu D, Jecu M, Geavlete P.

J Med Life. 2009 Apr-Jun;2(2):185-90.

PMID:
20108538
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.

Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M; Hexvix PCB301/01 Study Group.

J Urol. 2004 Jan;171(1):135-8.

PMID:
14665861
[PubMed - indexed for MEDLINE]
15.

Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL).

Bader MJ, Stepp H, Beyer W, Pongratz T, Sroka R, Kriegmair M, Zaak D, Welschof M, Tilki D, Stief CG, Waidelich R.

Urol Oncol. 2013 Oct;31(7):1178-83. doi: 10.1016/j.urolonc.2012.02.007. Epub 2012 Mar 21.

PMID:
22440147
[PubMed - indexed for MEDLINE]
17.

Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.

Witjes JA, Moonen PM, van der Heijden AG.

Eur Urol. 2005 Mar;47(3):319-22. Epub 2005 Jan 1.

PMID:
15716194
[PubMed - indexed for MEDLINE]
18.

Clinical and Cost Effectiveness of Hexaminolevulinate-guided Blue-light Cystoscopy: Evidence Review and Updated Expert Recommendations.

Witjes JA, Babjuk M, Gontero P, Jacqmin D, Karl A, Kruck S, Mariappan P, Palou Redorta J, Stenzl A, van Velthoven R, Zaak D.

Eur Urol. 2014 Nov;66(5):863-871. doi: 10.1016/j.eururo.2014.06.037. Epub 2014 Jul 4. Review.

PMID:
25001887
[PubMed - as supplied by publisher]
19.

HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.

Geavlete B, Jecu M, Multescu R, Georgescu D, Geavlete P.

Urology. 2010 Sep;76(3):664-9. doi: 10.1016/j.urology.2010.02.067. Epub 2010 Jun 8.

PMID:
20627289
[PubMed - indexed for MEDLINE]
20.

Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.

Mark JR, Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG.

Can J Urol. 2012 Apr;19(2):6227-31.

PMID:
22512972
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk